Checkpoint Therapeutics logo
Checkpoint Therapeutics CKPT
$ 3.66 8.6%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Checkpoint Therapeutics Balance Sheet 2011-2024 | CKPT

Annual Balance Sheet Checkpoint Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - -40.8 M -26.1 M -22 M -19.2 M -35.1 M -48 M - - - -

Long Term Debt

- - - - - - - - 2.47 M - - - -

Long Term Debt Current

- - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - 2.47 M - - - -

Total Current Liabilities

18.4 M 32.8 M 26 M 7.22 M 8.12 M 13.1 M 6.37 M 3.67 M 1.79 M - - - -

Total Liabilities

18.4 M 32.8 M 26 M 7.22 M 8.12 M 13.1 M 6.37 M 3.67 M 4.26 M - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-314 M -262 M -200 M -143 M -120 M -95.4 M -59 M -36.4 M -13.9 M - - - -

Total Assets

5.38 M 13.3 M 55.7 M 42.6 M 27 M 24.9 M 21.4 M 36 M 50.7 M - - - -

Cash and Cash Equivalents

4.93 M 12.1 M 54.7 M 40.8 M 26.1 M 22 M 19.2 M 35.1 M 50.4 M - - - -

Book Value

-13 M -19.5 M 29.7 M 35.4 M 18.8 M 11.8 M 15 M 32.3 M 46.4 M - - - -

Total Shareholders Equity

-13 M -19.5 M 29.7 M 35.4 M 18.8 M 11.8 M 15 M 32.3 M 46.4 M - - - -

All numbers in USD currency

Quarterly Balance Sheet Checkpoint Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

17.8 M 21.4 M 18.4 M 21.3 M 31.6 M 28.1 M 32.8 M 23 M 24.6 M 22.7 M 26 M 13 M 9.25 M 7.26 M 7.22 M 7.22 M 7.22 M 7.22 M 8.12 M 8.12 M 8.12 M 8.12 M 13.1 M 13.1 M 13.1 M 13.1 M 6.37 M 6.37 M 6.37 M 6.37 M 3.67 M 3.67 M 3.67 M 3.67 M 4.26 M 4.26 M - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-342 M -332 M -314 M -295 M -289 M -273 M -262 M -241 M -231 M -217 M -200 M -170 M -159 M -150 M -143 M -143 M -143 M -143 M -120 M -120 M -120 M -120 M -95.4 M -95.4 M -95.4 M -95.4 M -59 M -59 M -59 M -59 M -36.4 M -36.4 M -36.4 M -36.4 M -13.9 M -13.9 M - - - - - - - - - - - - - - - - - -

Total Assets

5.18 M 5.67 M 5.38 M 2.22 M 8.34 M 5.9 M 13.3 M 21.6 M 32.1 M 42.9 M 55.7 M 61 M 66.1 M 61.4 M 42.6 M 42.6 M 42.6 M 42.6 M 27 M 27 M 27 M 27 M 24.9 M 24.9 M 24.9 M 24.9 M 21.4 M 21.4 M 21.4 M 21.4 M 36 M 36 M 36 M 36 M 50.7 M 50.7 M - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

4.7 M 4.95 M 4.93 M 1.77 M 7.42 M 4.85 M 12.1 M 20.5 M 30.9 M 41.5 M 54.7 M 60.2 M 65.1 M 60 M 40.8 M 40.8 M 40.8 M 40.8 M 26.1 M 26.1 M 26.1 M 26.1 M 22 M 22 M 22 M 22 M 19.2 M 19.2 M 19.2 M 19.2 M 35.1 M 35.1 M 35.1 M 35.1 M 50.4 M 50.4 M - - - - - - - - - - - - - - - - - -

Book Value

-12.6 M -15.7 M -13 M -19 M -23.3 M -22.2 M -19.5 M -1.34 M 7.46 M 20.2 M 29.7 M 48 M 56.9 M 54.2 M 35.4 M 35.4 M 35.4 M 35.4 M 18.8 M 18.8 M 18.8 M 18.8 M 11.8 M 11.8 M 11.8 M 11.8 M 15 M 15 M 15 M 15 M 32.3 M 32.3 M 32.3 M 32.3 M 46.4 M 46.4 M - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

-12.6 M -15.7 M -13 M -19 M -23.3 M -22.2 M -19.5 M -1.34 M 7.46 M 20.2 M 29.7 M 48 M 56.9 M 54.2 M 35.4 M 35.4 M 35.4 M 35.4 M 18.8 M 18.8 M 18.8 M 18.8 M 11.8 M 11.8 M 11.8 M 11.8 M 15 M 15 M 15 M 15 M 32.3 M 32.3 M 32.3 M 32.3 M 46.4 M 46.4 M - - - - - - - - - - - - - - - - - -

All numbers in USD currency